ClinicalTrials.gg
RecruitingNCT07597603Updated Oct 7, 2026

Unconscious Mind Training

An interventional study of Intervention H22 in Memory Encoding, Memory and Behavior Change Interventions, sponsored by Dream Video LLC. Recruiting at 1 site in United States. Open to participants aged 10 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-07.

Sponsored by Dream Video LLC · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Not applicable
Ages
10 Years to 75 Years
Sex
All
01

Study summary

H22 - Unconscious Mind Training and Memory Encoding

Phase 2.1 in progress.

The core problem this clinical trial, H22, seeks to address is the pervasive challenge of modifying deeply ingrained, often unconscious, unwanted behaviors within the general population. Many individuals struggle with habits or actions that negatively impact quality of life, productivity, or well-being, yet conventional methods often fall short due to the unconscious nature of these behaviors.

Specifically, the trial aims to investigate the efficacy of H22, a novel intervention designed to engage and train the unconscious mind, in mitigating these unwanted behaviors. The central hypothesis guiding this research is that H22 training will empower volunteers to significantly reduce the frequency and intensity of identified unwanted behaviors.

Phase 1 Results:

The trial took place in Shagamu, Nigeria, between July 25, 2026, and August 7, 2026. The study monitored 20 participants over a 14-day intervention period, evaluating their baseline assessment scores, end-of-week progress across Weeks 1 and 2, and their decisions regarding whether to continue integrating Study H22 into daily life.

All 20 enrolled participants completed the full 14 days, yielding a 100% study retention rate. Participant scores improved significantly over the 14 days, increasing from a baseline average of 14.37 to 63.00 at Week 1, and reaching 99.40 by Week 2. At the conclusion of the trial, 85% of participants (17 of 20) chose to continue Study H22 in daily life.

Read the detailed description

This investigation will rigorously evaluate: Does H22 demonstrably lower the number of unwanted behaviors reported by participants over the trial period, indicating a tangible and measurable impact?

Timeline for Observable Results: What is the typical duration required to observe statistically significant results and behavioral changes when utilizing the H22 methodology, providing insights into its practical application and patient expectations?

To achieve these objectives, participants will engage in a structured and consistent protocol:

Daily H22 Engagement. Each volunteer will commit to performing the H22 training exercises daily for a continuous period of two weeks. This consistent engagement is crucial for assessing the cumulative impact of the intervention on unconscious conditioning.

Mid-Trial Unconscious Mind Survey: After the first week of the trial, participants will complete a specialized survey. This survey is designed to gather qualitative and quantitative data regarding perception of changes in participants unconscious thought patterns, behavioral triggers, and overall mental state as a result of H22.

Behavioral Monitoring Diary. Participants will maintain a daily diary to meticulously record the number of instances participants successfully remembered not to engage in their specified unwanted behavior. This self-reporting mechanism will provide critical empirical data to track progress and validate the effectiveness of H22 in promoting conscious control over previously unconscious actions.

Through this comprehensive approach, this study endeavors to determine if H22 offers a viable, innovative solution for behavioral modification by targeting the unconscious mind, thereby addressing a significant unmet need in personal development and therapeutic interventions.

The design of the intervention is centered around simplicity and consistency: a once-a-day engagement. This frequency is strategically chosen to:

Minimize Barriers to Entry: A short, daily commitment is less daunting than lengthy, infrequent sessions, increasing user adherence.

Promote Habit Formation: Regular, brief interaction facilitates the establishment of a sustainable routine, crucial for long-term results.

Optimize Efficacy: Consistent, focused engagement. The interventions provided by the Investigator are primarily behavioral. Investigators recognize that sustained improvement with the unconscious mind is more than just instruction; it demands a change in daily habits and a commitment to ongoing self-care.

02

Conditions studied

  • Memory Encoding
  • Memory
  • Behavior Change Interventions
  • Habits

Browse trials for

Keywords

  • Behavior
  • Cognitive ability
  • Unconscious mind
03

In context

Habits

61 studies on the registry are indexed under Habits; 13 are open to participants now.

This study's planned enrollment of 100 is below the median of 125 across 47 interventional studies indexed under Habits.

Browse Habits studies →

Lead sponsor

Dream Video LLC is the lead sponsor of 3 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Can read and write
  • Willing and able to follow the requirements of the protocol

Exclusion criteria

Exclusion Criteria:

- Medical instability, restlessness, or other factors that would compromise data acquisition

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Experimental
    H22 #1

    H22 interventions are administered once daily over a period of fourteen days.

    Behavioral: Intervention H22

Interventions

  • BehavioralIntervention H22

    Unconscious Mind Training.

06

What researchers measure

Primary outcomes

  1. Proportion of volunteers achieving measurable improvements with unconscious training following a two-week treatment protocol.

    Time frame: From enrollment to the end of treatment at 2 weeks

  2. Compare the number of participants experiencing treatment-related adverse events versus those with positive treatment outcomes.

    Time frame: From enrollment to the end of treatment at 2 weeks.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Meng F, Li A, You Y, Xie C. Motor expertise modulates unconscious rather than conscious executive control. PeerJ. 2019 Feb 5;7:e6387. doi: 10.7717/peerj.6387. eCollection 2019. PubMed 30740277 ↗
  • Desender K, Van Lierde E, Van den Bussche E. Comparing conscious and unconscious conflict adaptation. PLoS One. 2013;8(2):e55976. doi: 10.1371/journal.pone.0055976. Epub 2013 Feb 6. PubMed 23405242 ↗
  • Gantman AP, Adriaanse MA, Gollwitzer PM, Oettingen G. Why did I do that? Explaining actions activated outside of awareness. Psychon Bull Rev. 2017 Oct;24(5):1563-1572. doi: 10.3758/s13423-017-1260-5. PubMed 28315169 ↗
  • Williams LE, Bargh JA, Nocera CC, Gray JR. The unconscious regulation of emotion: nonconscious reappraisal goals modulate emotional reactivity. Emotion. 2009 Dec;9(6):847-54. doi: 10.1037/a0017745. PubMed 20001127 ↗
  • Bargh JA, Gollwitzer PM, Lee-Chai A, Barndollar K, Trotschel R. The automated will: nonconscious activation and pursuit of behavioral goals. J Pers Soc Psychol. 2001 Dec;81(6):1014-27. PubMed 11761304 ↗
  • Bargh JA, Morsella E. The Unconscious Mind. Perspect Psychol Sci. 2008 Jan;3(1):73-9. doi: 10.1111/j.1745-6916.2008.00064.x. PubMed 18584056 ↗

Individual participant data

Plan to share: No

09

Updates

1 registry update since Sep 25, 2026
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date and description
1 update, last Oct 7, 2026
Show all 1 update
  1. Oct 7, 2026
    Minor edits only
    + 2 other changes: verification date and description

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07597603
Lead sponsor
Dream Video LLC
Collaborators
Dream Holdings Research
Responsible party
Sponsor
First posted
May 19, 2026
Start date
Jul 2027 (estimated)
Primary completion
Jan 2028 (estimated)
Completion
Jan 2028 (estimated)
Last update
Oct 7, 2026

Study contacts

Matthew Quitto II
Contact
dream@dreamholdingsllc.com
9173422895
Matthew Quitto II
study director · Dream Video LLC

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion